PPD, Inc. Awarded U.S. Army Contract to Support Biodefense and Vaccine Development Programs

PPD, Inc. (Nasdaq: PPDI) today announced it has been awarded the U.S. Army Medical Research Acquisition Activity: Regulatory Affairs & Compliance Support contract to provide global regulatory and biostatistical services for a range of clinical development programs funded by the U.S. Army.

Back to news